Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599298-25-000023
Filing Date
2025-01-06
Accepted
2025-01-06 19:05:34
Documents
4
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1736208323.html 4  
1 FORM 4 wk-form4_1736208323.xml 4 6660
2 EX-24 kclark-executedpoaforedg.htm EX-24 5155
3 GRAPHIC kclark-executedpoaforedg001.jpg GRAPHIC 274112
4 kclark-executedpoaforedg002.jpg GRAPHIC 34768
  Complete submission text file 0001599298-25-000023.txt   439027
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVE. SUNNYVALE CA 94085
Business Address
Clark Kenneth A (Reporting) CIK: 0001561736 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 25512933

Mailing Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131
Business Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131 305-203-2034
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

EIN.: 371979717 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)